Teresa M. DeLuca's most recent trade in LifeStance Health Group Inc was a trade of 35,714 Common Stock done . Disclosure was reported to the exchange on June 11, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| LifeStance Health Group Inc | Teresa M. DeLuca | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2025 | 35,714 | 107,288 | - | 0 | Common Stock | |
| Surgery Partners Inc | Teresa M. DeLuca | Director | Grant, award, or other acquisition of securities at price $ 23.32 per share. | 10 Jun 2025 | 6,861 | 65,191 (0%) | 0% | 23.3 | 159,999 | Common Stock |
| LifeStance Health Group Inc | Teresa M. DeLuca | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Aug 2024 | 35,211 | 71,574 | - | 0 | Common Stock | |
| LifeStance Health Group Inc | Teresa M. DeLuca | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jul 2024 | 36,363 | 36,363 | - | 0 | Common Stock | |
| Surgery Partners Inc | Teresa M. DeLuca | Director | Grant, award, or other acquisition of securities at price $ 25.93 per share. | 06 Jun 2024 | 6,170 | 58,330 (0%) | 0% | 25.9 | 159,988 | Common Stock |
| Surgery Partners Inc | Teresa M. DeLuca | Director | Grant, award, or other acquisition of securities at price $ 38.16 per share. | 01 Jun 2023 | 4,192 | 52,160 (0%) | 0% | 38.2 | 159,967 | Common Stock |
| Surgery Partners Inc | Teresa M. DeLuca | Director | Purchase of securities on an exchange or from another person at price $ 24.50 per share. | 21 Nov 2022 | 20,000 | 47,968 (0%) | 0% | 24.5 | 490,000 | Common Stock |
| Surgery Partners Inc | Teresa M. DeLuca | Director | Grant, award, or other acquisition of securities at price $ 39.70 per share. | 20 May 2022 | 4,030 | 27,968 (0%) | 0% | 39.7 | 159,991 | Common Stock |
| 180 Life Sciences Corp | Teresa M. DeLuca | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2022 | 21,000 | 21,000 | - | - | Non-Qualified Stock Option (right to buy) | |
| Surgery Partners Inc | Teresa M. DeLuca | Director | Sale of securities on an exchange or to another person at price $ 53.50 per share. | 24 Mar 2022 | 1,535 | 23,938 (0%) | 0% | 53.5 | 82,123 | Common Stock |
| 180 Life Sciences Corp | Teresa M. DeLuca | Director | Purchase of securities on an exchange or from another person at price $ 4.00 per share. | 09 Dec 2021 | 5,000 | 5,000 | - | 4 | 20,000 | Common Stock |
| 180 Life Sciences Corp | Teresa M. DeLuca | Director | Purchase of securities on an exchange or from another person at price $ 3.99 per share. | 09 Dec 2021 | 2,500 | 2,500 | - | 4.0 | 9,975 | Common Stock |
| 180 Life Sciences Corp | Teresa M. DeLuca | Director | Purchase of securities on an exchange or from another person at price $ 3.98 per share. | 09 Dec 2021 | 2,500 | 2,500 | - | 4.0 | 9,950 | Common Stock |
| 180 Life Sciences Corp | Teresa M. DeLuca | Director | Purchase of securities on an exchange or from another person at price $ 3.95 per share. | 09 Dec 2021 | 2,500 | 2,500 | - | 4.0 | 9,875 | Common Stock |
| 180 Life Sciences Corp | Teresa M. DeLuca | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Aug 2021 | 79,000 | 79,000 | - | - | Non-Qualified Stock Option (right to buy) |